MODERN OUTLOOKS OF THE CORRELATION BETWEEN THE BODY MASS INDEX AND PATHOLOGICAL CHANGES IN THE ORGANS OF THE ORAL CAVITY

Hordiienko L. P.

LITERATURE REVIEWS

Scentific article

In a review article summarizes the data of the scientific literature related to the problem of the correlation between the body mass index and pathological changes in the organs of the oral cavity. Today it has been proven that overweight and obesity are important risk factors for dental health of people of all ages. Obesity is a complex and multifactorial disease. His relationship to the health of the oral cavity is actively investigated by scientists. According to the World Health Organization, 1.9 billion adults, 18 years and older, are overweight. Of these over 600 million were obese. The body mass index (BMI) is used to quantify the fat depot in the body. Indicator of BMI from 18.5 to 24.9 is considered normal; from 25.0 to 29.9 reflects excess body weight, more than 30.0 indicates to obesity development. The aim of the study was to analyze a modern scientific literature on the correlation between BMI and the oral health. Metabolic disorders in the human body in the conditions of obesity are systemic causative factors of the development of periodontal diseases. According to epidemiological studies, toothless men and women have, on average, higher BMI and visceral obesity, compared to those who have teeth. The adverse effects of obesity on periodontium may be mediated by the action of such proinflammatory cytokines as interleukins (IL-1, IL-6 and TNF-α), adipokines (leptin, adiponectin, resistin and plasminogen activator inhibitor-1), and a number of other biologically active substances, such as reactive oxygen species, which can directly affect the periodontal tissues. Obesity increases the susceptibility to infectious agents by modulating the immune and inflammatory response, resulting in an increased risk of periodontitis. Obesity adversely affects the cell-mediated immune response and reduces the immune function of lymphocytes and the activity of natural killer T cells. In a number of clinical trials and meta-analyzes, it has been shown that patients with obesity have a more severe course of inflammatory periodontal disease. A number of authors in their studies emphasize that weight gain and obesity are one of the factors that lead to caries development, even in childhood. A number of studies have established a positive correlation between dental caries and BMI. It has been established that obesity leads to the development of hyposalivation in adults and children. However, the relationship between hyposalation and obesity is not sufficiently investigated. Some scientists have suggested that inflammatory mediators play an important role in hypofunction of salivary glands in obesity. The effects of prolonged hyposalivation are determined by the decreased physiological functions of saliva. Reduced secretion of saliva and changes in the composition of saliva cause development of pathological processes in the oral cavity and other parts of the gastrointestinal tract. Thus, the analysis of modern scientific literature suggests that the increase in the body mass index, regardless of other risk factors, leads to pathological changes in the organs of the oral cavity. Undoubtedly, the foregoing stipulates the need for a continuous expansion of research aimed at developing new approaches to prevent the development of dental diseases in people with excessive body weight and obesity.

body mass index, obesity, periodontitis, caries, salivary glands

1. Bezvushko EV, Kostura VL. Urazhenist kariesom postiynih zubiv u ditey z nadmirnoyu masoyu tila. Visnik problem biologiyi i meditsini. 2015; 3(2):351-4. [in Ukrainian].
2. Emelyanova NYu, Emelyanov DV. Analiz stomatologicheskogo statusa u bolnyih s izbyitochnoy massoy tela: mezhdistsiplinarnyiy podhod. Ukrayinskiy terapevtichniy zhurnal. 2011;3:79-81. [in Russian].
3. Ermolaeva LF, Shishkin AN, Sheveleva NA, Sheveleva MA, Penkovoy EA. Ozhirenie i zabolevaniya parodonta. World Science. 2015;2(3):54-6. [in Russian].
4. Glazunov OA, Meladze IN, Glazunova SO. Osoblivosti mikrobiotsenozu parodontalnih kishen ta stan mistsevogo imunitetu u hvorih na generalizovaniy parodontit na foni ozhirinnya, uskladnenogo metabolichnim sindromom. Klinichna ta eksperimentalna patologiya. 2017;13(1):63-7. [in Ukrainian].
5. Hordiienko LP. Oksidativniy stres – providniy mehanizm rozvitku patologichnih zmin v slinnih zalozah za umov eksperimentalnogo ozhirinnya. Aktualni problemi suchasnoyi meditsini: Visnik UMSA. 2014;14,4(48):183-6. [in Ukrainian].
6. Kaydashev IP. Aktivatsiya NF-kB pri metabolichnomu sindromi. Fiziologichniy zhurnal. 2012;58(1):93-101. [in Ukrainian].
7. Kaydashev IP. NF-kB-signalizatsiya kak osnova razvitiya sistemnogo vospaleniya, insulinorezistentnosti, lipotoksichnosti, saharnogo diabeta 2-go tipa i ateroskleroza. Mezhdunarodnyiy endokrinologicheskiy zhurnal. 2011;3(35):35-44. [in Russian].
8. Lebid OI, Shmanko VV. Vpliv kombinovanogo zastosuvannya antiseptika ta fitozboru na stan gumoralnogo imunitetu pri zahvoryuvannyah parodontu u ditey z alimentarno-konstitutsiynim ozhirinnyam. Visnik problem biologiyi і meditsini. 2013;2(4):119-22. [in Ukrainian].
9. Lebid OI, Zayats VE. Kliniko-patogenetichni osoblivosti zahvoryuvan tkanin parodonta u ditey iz nadmirnoyu masoyu tila (oglyad literaturi). Klinichna stomatologiya. 2011;1:11-4. [in Ukrainian].
10. Lyashuk RP, Lyashuk PM, Marchuk YuF, Shodnitskiy IV, Melnik LM. Komorbidnist tsukrovogo diabetu tipu 2 ta ozhirinnya (oglyad literaturi). Klinichna ta eksperimentalna patologiya. 2016;15(1):198-200. [in Ukrainian].
11. Mazur IP, Gosteva ZV. Provedennya kompleksnogo likuvannya patsientiv z generalizovanim parodontitom na foni metabolichnogo sindromu. Visnik problem biologiyi і meditsini. 2015;2(2):170-4. [in Ukrainian].
12. Petruhina NB, Denga AE, Shnayder SA, Efremova OV. Stomatologicheskiy status i effektivnost lechebno-profilakticheskih meropriyatiy s izbyitochnoy massoy tela. Farmateka. 2015;2:28-34. [in Russian].
13. Petruhina NB, Zorina OA, Rabinovich IM, Shilov AM. Epidemiologicheskie vzaimosvyazi parodontita, disbioza kishechnika, aterogennoy dislipidemii pri metabolicheskom sindrome. Stomatologiya. 2015;2:16-9. [in Russian].
14. Romanova YG, Tsushko IA. Rol mikrobiotsinoza polosti rta u lits molodogo vozrasta s alimentarno-konstitutsionnyim ozhireniem. Journal of Health Sciences. 2014;4(7):83-92. [in Russian].
15. Tarasenko LM, Suhanova GA, Mischenko VP, Neporada KS. Slyunnyie zhelezyi. Biohimiya, fiziologiya, klinicheskie aspektyi. Tomsk: NTL; 2002. 124 s. [in Russian].
16. Tsushko IO, Denga AE, Shnayder SA, Efremova OV. Stomatologicheskiy status i effektivnost lechebno-profilakticheskih meropriyatiy s izbyitochnoy massoy tela. Visnyk stomatologiy. 2017;1:50-3. [in Russian].
17. Al-Rawi N, Al-Marzooq F. The relation between periodontopathogenic bacterial levels and resist in the saliva of obese type 2 diabetic patients. J Diabetes Res. 2017;2017:1-7.
18. Ashwini R, Priya NK, Nandini DB. Obesity and Oral health – A review. Journal of Dental Practice and Research. 2013;1(2):30-5.
19. Benguigui C, Bongard V, Ruidavets JB, Sixou M, Chamontin B, Ferrieres J, et al. Evaluation of oral health related to body mass index. Oral Diseases. 2012;18:748-55.
20. Boesing F, Patio JS, Silva VR. The interface between obesity and periodontitis with emphasis on oxidative stress and inflammatory response. Obes Rev. 2009;10(3):290-97.
21. Delzenne N, Cani P. Interaction between obesity and the gut microbiota: relevance in nutrition. Ann Rev of Nutrition. 2011;31:15-31.
22. Dursun E, Akalın FA, Genc T, Cinar N, Erel O, Yildiz BO. Oxidative Stress and Periodontal Disease in Obesity. Medicine. 2016 March;95(12):1-7.
23. Flink H, Bergdahl M, Tegelberg A, Rosenblad A, Lagerlof F. Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults. Community Dent Oral Epidemiol. 2008;36(6):523-31. 
24. Guare RO, Ciamponi AL, Santos MT. Caries experience and salivary parameters among overweight children and adolescents. Dent. J. 2013;1:31-40.
25. Mathison RD. Salivary glands and adipobiology. Adipobiology. 2012;4:51-8.
26. Mozaffari MS, Abdelsayed R, Zakhary I, El-Salanty M, Liu JY, Wimborne H, et al. Submandibular gland and caries susceptibility in the obese Zucker rat. J Oral Pathol Med. 2011;40(2):194-200.
27. Ostberg AL, Bengtsson C, Lissner L, Hakeberg M. Oral health and obesity indicators. BMC Oral Health. 2012;12(50):1-7.
28. Pannunzio E, Amancio OM, Vitalle MS, Souza DN, Mendes FM, Nicolau J. Analysis of the stimulated whole saliva in overweight and obese school children. Rev Assoc Med Bras. 2010;56(1):32-6. 
29. Rabiei M, Saberi BV, Rad HM, Khazan SA. The relation between obesity and oral health. Caspian J of Dent Res. 2017 March;6(1):36-44.
30. Saez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, Plaza-Diaz J, Gil A. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials. Int J Mol Sci.2016;17(6). 
31. Suvan J, D’Aiuto F. Assessment and Management of Oral Health in Obesity Curr Obes Rep. 2013;2:142-9.
32. Tonetti M.S, Van Dyke T. Periodontitis and atherosclerotic cardiovascular disease. Consensus report of working group 1 of the Joint European Federation of Periodontology and American Academy of Periodontology Workshop on Periodontitis and Systemic Diseas. J Clin Periodontal 2013;40:24-9.
33. Trembley M, Gaudet D, Brisson D. Metabolic syndrome and oral markers of cardiometabolic risk. J Can Dent Assoc. 2011;77:1-7.
34. Ueda H, Yagi T, Amitani H, Asakawa A, Ikeda S, Miyawaki S, et al. The roles of salivary secretion, brain-gut peptides, and oral hygiene in obesity. Obes Res Clin Pract.2013 Sep-Oct;7(5):e321-9.
35. WHO: Obesity and overweight: Fact sheet N. 311. Accessed 2017 May 31. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
36. Zolotukhin S. Metabolic hormons in saliva. Oral Dis. 2013;19(3):219-29.

«Bulletin of problems biology and medicine» Issue 1 Part 1 (142), 2018 year, 30-34 pages, index UDK 616.31:616-056.5

10.29254/2077-4214-2018-1-1-142-30-34